Battezzati A, Haisch M, Brillon DJ, Matthews DE. Splanchnic utilization of enteral alanine in humans. Metabolism 1999;48:915-21. View abstract.
Bodamer OA, Haas D, Hermans MM, et al. L-alanine supplementation in late infantile glycogen storage disease type II. Pediatr Neurol 2002;27:145-6. View abstract.
Bodamer OA, Halliday D, Leonard JV. The effects of L-alanine supplementation in late-onset glycogen storage disease type II. Neurology 2000;55:710-2. View abstract.
D'Aniello A, Vetere A, Fisher GH, et al. Presence of D-alanine in proteins of normal and Alzheimer human brain. Brain Res 1992;592:44-8. View abstract.
Evans ML, Hopkins D, Macdonald IA, Amiel SA. Alanine infusion during hypoglycaemia partly supports cognitive performance in healthy human subjects. Diabet Med 2004;21:440-6. View abstract.
Fisher GH, D'Aniello A, Vetere A, et al. Free D-aspartate and D-alanine in normal and Alzheimer brain. Brain Res Bull 1991;26:983-5. View abstract.
Koeslag JH, Levinrad LI, Lochner JD, Sive AA. Post-exercise ketosis in post-prandial exercise: effect of glucose and alanine ingestion in humans. J Physiol 1985;358:395-403. View abstract.
Mundy HR, Williams JE, Cousins AJ, Lee PJ. The effect of L-alanine therapy in a patient with adult onset glycogen storage disease type II. J Inherit Metab Dis 2006;29:226-9. View abstract.
Patra FC, Sack DA, Islam A, et al. Oral rehydration formula containing alanine and glucose for treatment of diarrhoea: a controlled trial. BMJ 1989;298:1353-6. View abstract.
Ribeiro Junior Hda C, Lifshitz F. Alanine-based oral rehydration therapy for infants with acute diarrhea. J Pediatr 1991;118(4 ( Pt 2)):S86-90. View abstract.
Saleh TY, Cryer PE. Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM. Diabetes Care 1997;20:1231-6. View abstract.
Sazawal S, Bhatnagar S, Bhan MK, et al. Alanine-based oral rehydration solution: assessment of efficacy in acute noncholera diarrhea among children. J Pediatr Gastroenterol Nutr 1991;12:461-8. View abstract.
Tsai GE, Yang P, Chang YC, Chong MY. D-alanine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 2006;59:230-4. View abstract.
Wiethop BV, Cryer PE. Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 1993;16:1131-6. View abstract.
Wiethop BV, Cryer PE. Glycemic actions of alanine and terbutaline in IDDM. Diabetes Care 1993;16:1124-30. View abstract.
Battezzati A, Haisch M, Brillon DJ, Matthews DE. Splanchnic utilization of enteral alanine in humans. Metabolism 1999;48:915-21. View abstract.
Bodamer OA, Haas D, Hermans MM, et al. L-alanine supplementation in late infantile glycogen storage disease type II. Pediatr Neurol 2002;27:145-6. View abstract.
Bodamer OA, Halliday D, Leonard JV. The effects of L-alanine supplementation in late-onset glycogen storage disease type II. Neurology 2000;55:710-2. View abstract.
Capitão LP, Forsyth J, Thomaidou MA, Condon MD, Harmer CJ, Burnet PW. A single administration of 'microbial' D-alanine to healthy volunteers augments reaction to negative emotions: A comparison with D-serine. J Psychopharmacol 2020;34(5):557-566. View abstract.
D'Aniello A, Vetere A, Fisher GH, et al. Presence of D-alanine in proteins of normal and Alzheimer human brain. Brain Res 1992;592:44-8. View abstract.
Dandare SU, Ezeonwumelu IJ, Shinkafi TS, Magaji UF, Adio AA, Ahmad K. L-alanine supplementation improves blood glucose level and biochemical indices in alloxan-induced diabetic rats. J Food Biochem 2021;45(1):e13590. View abstract.
Evans ML, Hopkins D, Macdonald IA, Amiel SA. Alanine infusion during hypoglycaemia partly supports cognitive performance in healthy human subjects. Diabet Med 2004;21:440-6. View abstract.
Ezeonwumelu IJ, Mode AM, Magaji UF, et al. Coadministration of L-alanine and L-glutamine ameliorate blood glucose levels, biochemical indices and histological features in alloxan-induced diabetic rats. J Food Biochem 2022;46(12):e14420. View abstract.
Fisher GH, D'Aniello A, Vetere A, et al. Free D-aspartate and D-alanine in normal and Alzheimer brain. Brain Res Bull 1991;26:983-5. View abstract.
Koeslag JH, Levinrad LI, Lochner JD, Sive AA. Post-exercise ketosis in post-prandial exercise: effect of glucose and alanine ingestion in humans. J Physiol 1985;358:395-403. View abstract.
Mundy HR, Williams JE, Cousins AJ, Lee PJ. The effect of L-alanine therapy in a patient with adult onset glycogen storage disease type II. J Inherit Metab Dis 2006;29:226-9. View abstract.
Patra FC, Sack DA, Islam A, et al. Oral rehydration formula containing alanine and glucose for treatment of diarrhoea: a controlled trial. BMJ 1989;298:1353-6. View abstract.
Ribeiro Junior Hda C, Lifshitz F. Alanine-based oral rehydration therapy for infants with acute diarrhea. J Pediatr 1991;118(4 ( Pt 2)):S86-90. View abstract.
Saleh TY, Cryer PE. Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM. Diabetes Care 1997;20:1231-6. View abstract.
Sazawal S, Bhatnagar S, Bhan MK, et al. Alanine-based oral rehydration solution: assessment of efficacy in acute noncholera diarrhea among children. J Pediatr Gastroenterol Nutr 1991;12:461-8. View abstract.
Soto-Mota A, Norwitz NG, Evans RD, Clarke K. Exogenous d-ß-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis. Endocrinol Diabetes Metab 2022;5(1):e00300. View abstract.
Tsai GE, Yang P, Chang YC, Chong MY. D-alanine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 2006;59:230-4. View abstract.
Umeda K, Shindo D, Somekawa S, et al. Effects of Five Amino Acids (Serine, Alanine, Glutamate, Aspartate, and Tyrosine) on Mental Health in Healthy Office Workers: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial. Nutrients 2022;14(11):2357. View abstract.
Wiethop BV, Cryer PE. Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 1993;16:1131-6. View abstract.
Wiethop BV, Cryer PE. Glycemic actions of alanine and terbutaline in IDDM. Diabetes Care 1993;16:1124-30. View abstract.